check_circleStudy Completed
Bayer Identifier:
16411
ClinicalTrials.gov Identifier:
Not Available
EudraCT Number:
Not Available
EU CT Number:
Not Available
SD/MD study in Chinese,BAY1192631, ICPP
Trial purpose
Key Participants Requirements
Sex
N/AAge
N/ATrial summary
Enrollment Goal
N/ATrial Dates
June 2014 - August 2014Phase
Phase 1Could I Receive a placebo
N/AProducts
Sivextro (Tedizolid phosphate, BAY119-2631)Accepts Healthy Volunteer
N/AWhere to participate
Status | Institution | Location |
---|---|---|
Completed | Beijing, 100730, China |
Trial design
Trial Type
InterventionalIntervention Type
N/ATrial Purpose
N/AAllocation
N/ABlinding
N/AAssignment
N/ATrial Arms
N/A